{"transactions":[{"id":1097736,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":77854,"kind":"person","name":"Anderson Cynthia Lynn","position":1,"cik":"0001989905","reported_name":"Anderson Cynthia Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-07-01T21:49:44.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":6617,"price":1.7,"value":11248.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."}],"balance_after":12801,"source":{"system":"sec-edgar","filing":"0001415889-25-018751","document":"form4-07012025_090741.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588925018751/form4-07012025_090741.xml","form_type":"4"}},{"id":1101627,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":77854,"kind":"person","name":"Anderson Cynthia Lynn","position":1,"cik":"0001989905","reported_name":"Anderson Cynthia Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:15:12.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (the \"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 23, 2025 (the \"Grant Date\"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Grant Date."}],"balance_after":100000,"derivative":{"exercise_price":1.96,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-018203","document":"form4-06252025_050607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588925018203/form4-06252025_050607.xml","form_type":"4"}},{"id":1304243,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":77854,"kind":"person","name":"Anderson Cynthia Lynn","position":1,"cik":"0001989905","reported_name":"Anderson Cynthia Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-13T22:39:30.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":2592,"price":2.5075,"value":6499.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019  Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d)."}],"balance_after":6184,"source":{"system":"sec-edgar","filing":"0001415889-25-001396","document":"form4-01132025_100126.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588925001396/form4-01132025_100126.xml","form_type":"4"}},{"id":1462615,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":77854,"kind":"person","name":"Anderson Cynthia Lynn","position":1,"cik":"0001989905","reported_name":"Anderson Cynthia Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-02T22:08:51.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":3592,"price":2.958,"value":10625.136,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended."}],"balance_after":3592,"source":{"system":"sec-edgar","filing":"0001415889-24-019024","document":"form4-07022024_100748.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588924019024/form4-07022024_100748.xml","form_type":"4"}},{"id":1468673,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":77854,"kind":"person","name":"Anderson Cynthia Lynn","position":1,"cik":"0001989905","reported_name":"Anderson Cynthia Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-27T01:30:06.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options (the \"Options\") granted pursuant to the Issuer's Amended and Restated 2019 Equity Omnibus Incentive Plan, as amended. The Options will begin vesting on June 24, 2024 (the \"Vesting Start Date\"), and will vest in equal monthly installments over a three-year period until the Options become fully vested on the three (3) year anniversary of the Vesting Start Date."}],"balance_after":150000,"derivative":{"exercise_price":3.23,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-24-018277","document":"form4-06272024_010602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588924018277/form4-06272024_010602.xml","form_type":"4"}},{"id":1798567,"issuer":{"id":7955,"kind":"organization","name":"Vistagen Therapeutics, Inc."},"owners":[{"id":77854,"kind":"person","name":"Anderson Cynthia Lynn","position":1,"cik":"0001989905","reported_name":"Anderson Cynthia Lynn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2023-08-23T17:09:47.000Z","date":"2023-08-21","kind":"grant","planned":false,"acquired":true,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were granted in connection with the Reporting Person's appointment as Chief Financial Officer and pursuant to the Issuer's 2019 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the stock options vest on August 21, 2024 (the \"Vesting Start Date\") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date."}],"balance_after":8333,"derivative":{"exercise_price":5.34,"expiration_date":"2033-08-21","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001415889-23-012532","document":"form4-08232023_050842.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1411685/000141588923012532/form4-08232023_050842.xml","form_type":"4"}}]}